FDA Investigator Ravi S Harapanhalli
Ravi S Harapanhalli has conducted inspections on 2 sites in 1 countries as of 03 May 2004. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
03 May 2004
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Ravi S Harapanhalli:
Ashar P Parikh,
Carl Lee,
CDR Rochelle B Young, RPh, MSA,
Daniel J Roberts,
James C Lee, PharmD,
Jeffrey M Watson,
Joanne Hosting,
John A Gonzalez,
Karen D Phung,
Kevin P Foley,
LCDR Jennifer H Rhyu,
Linda Thai,
Lucila B Nwatu,
Lynda L Perry, PhD,
Mark E Chan,
Peter E Baker,
Raymond T Oji,
Sandra S Saniga,
Uduak M Inokon,
Walden H Lee
Ravi S Harapanhalli's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2004 | FDA 483 | ALZA Corporation - Form 483, 2004-05-14 |
June, 2004 | FDA 483 | ALZA Corporation - Form 483, 2004-06-16 |
May, 2004 | EIR | Alza Corporation - EIR, 2004-07-12 |
June, 2004 | EIR | ALZA Corporation - EIR, 2004-07-12 |
June, 2004 | EIR | ALZA Corporation - EIR, 2004-06-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more